Copyright C)1977 American Society forMicrobiology Printed in U.S.A.
Rapid Diagnosis of Lymphocytic
Meningitis by
Frequency-Pulsed Electron
Capture Gas-Liquid Chromatography:
Differentiation
of Tuberculous;
Cryptococcal, and Viral
Meningitis
ROBERT B. CRAVEN, JOHN B. BROOKS,* DAVID C. EDMAN,1 JAMES D. CONVERSE,' JOHN GREENLEE,2 DAVID SCHLOSSBERG,3 THOMAS FURLOW,2 JACK M. GWALTNEY, JR.,I AND
WALTER F. MINER'
Centerfor DiseaseControl, Public HealthService, U.S. Department of Health, Education,and Welfare, Atlanta,Georgia30333
Received for publication7March1977
Cerebrospinal fluid specimens from patients with tuberculous (17 cases),
cryptococcal (15 cases), and viral (14 cases) meningitis were analyzed by
fre-quency-pulsed electroncapturegas-liquid chromatography andmass
spectrome-try.Compounds that disappeared after therapywerefoundtobepresentineach
ofthese specimens andwerenotdetectedincontrols. They occurredin repetitive
patterns such that these three types of meningitis could be rapidly
distin-guished. The compoundassociated with tuberculousmeningitishasbeen
tenta-tively identified. These findings have implications for rapid diagnosis,
patho-physiological studies, and possiblenewtherapeutic approaches.
Gas-liquid chromatography (GLC) has been
usedtodifferentiatevariousspeciesof bacteria
by analysis of theirmetabolicproductsinspent
culture mediaorof theircell wall constituents
(6, 8-11, 12, 19-24). More recently, the
tech-nique has been applied to the study of body
fluids during infection (2, 6a, 7, 25; J. B.
Brooks, R. B. Craven, D. Schlossberg, C. C.
Alley, and F. M. Pitts, submitted for
publica-tion). Schlossbergetal., using GLC
techniques
developed
inthislaboratory, demonstrated thepossible rapid diagnosisofcryptococcal
menin-gitis (25). The difficulty in obtaining timely laboratory confirmationof theagent
producing
lymphocytic meningitis, e.g., cryptococcal,
tu-berculous,
orviral, prompted
the presentin-vestigationof GLC as arapid etiological
diag-nostic method.
MATERIALS AND METHODS
CSF specimens. All specimens were the excess
left after routine laboratorystudieswereperformed. Control specimens consisted of the excess cerebro-spinal fluid (CSF) from myelograms or spinal epi-duralanesthesia andwerebacteriologicallyculture
negative, with normalcellcount, glucose, and
pro-tein.
Twelveculture-positive specimens frompatients
IPresentaddress: U.S. Naval Medical Research Unitno.
3,FPO, NY09527.
:2Presentaddress:University ofVirginiaSchool of Medi-cine,Charlottesville,VA 22904.
3Presentaddress:Emory UniversitySchoolofMedicine, Atlanta,GA 30322.
withtuberculous meningitis were obtained from the meningitis research ward of the U.S. Naval Medical Research Unit no. 3 (NAMRU-3), Cairo, Egypt. Seven samples from cryptococcal meningitis
pa-tientswerecollected by us, and an additional eight sampleswereprovided byLeoKaufman'slaboratory
atthe Center forDiseaseControl (CDC)inAtlanta, Ga.Theseeight samples were from specimens sub-mitted by the University Collaborative Study of Cryptococcal Meningitis to be analyzed for crypto-coccalantigen. Allcryptococcal specimens were cul-turepositive orantigenpositive orboth.
We collected five specimens from patients with clinically diagnosed aseptic meningitis, three from
oneclustered outbreak and two from another. We
also obtainedCSFfrompatients withbiopsy-proven herpes simplexencephalitis andtwospecimens from patients with encephalitis associated with herpes
zoster skin infection of the face. Anumber of cul-ture-documented specimens of viralmeningitis and encephalitis wereprovided by Richard Emmons of the CaliforniaDepartment of Health.One specimen was from a patient with toxoplasmosis meningitis (14).
Apparatus. APerkin-Elmer gas chromatograph, model 900, equipped with a 63Ni 10-mCi frequency
pulse-modulated electron capture (EC) detector,
switching valves, and a25.4-cm potentiometric re-corder,wasused.The instrumentwasoperatedwith
twocoiledglass columns (0.3 cm in IDby7.3m in
length). One column (nonpolar) was packed with Chromosorb W, 80/100 mesh (AW-DMCS H.P.),
coated with 3% OV-1 (Applied Science
Laborato-ries).Thesecondcolumn(polar)waspackedwith3%
Dexsil410 (Analabs). Theswitchingvalves
permit-ted a comparative analysis of the effluent from 27
on February 7, 2020 by guest
http://jcm.asm.org/
28 CRAVEN ET AL.
either column through asingle detector. Reagents
and instrument settings were as previously
pub-lished(1, 3,4). A Perkin-Elmer PEP-1 datasystem with Modular Software 2, Revision C, was usedto
refine dataandtotentatively identify compounds by
their retention times, as previously determined
fromanalysisofstandard mixtures(5).
Derivatization procedures. Derivitization
proce-dures have been described in detail elsewhere(1, 3,
4). Toexploitthespecificityof the ECdetector, we
formedelectron-capturingderivatives ofacids,
alco-hols, and amines before GLC analysis as follows
(15). A 2-ml specimen of CSF was acidified to
ap-proximately pH 2 by adding0.1 ml of 50% H2SO4.
Theacidified samplewasextractedby shakingwith 20mlof6%ethanolinchloroformtoobtain acids and alcohols. Thechloroform-ethanolwasremoved,and
the samplewasmade basic (pH 10)and re-extracted
for amines with 20 ml of chloroform. ThepH2and
pH 10fractionswereput into separate 50-ml
beak-ersandevaporatedtoabout 1 ml with astreamof
clean dryair.Thesamplesweretransferredto12-by
75-mmtesttubes withdisposable Pasteurpipettes;
anyvisiblewaterlayerwasdiscarded.
Sampleswerefurtherdriedby adding 100mgof
MgSO4tothe concentrate andshaking. Next, they
were centrifuged, and the solvent layer was
re-moved to a clean 12-by 75-mmtesttube. The
re-mainingMgSO4waswashed with1mlof chloroform
andcentrifuged; thechloroformlayerwasdecanted
andcombined with thepreviouslydecanted solvent. TheMgSO4 wasdiscarded. Thesamples were
con-centrated undera gentle stream of airto
approxi-mately0.1ml.
Acids and alcoholspresentinthe pH2 fractions
weretreatedwithtrichloroethanoland
heptafluoro-butyric and anhydride (HFBA) to form
electron-capturing derivatives as follows: 1 drop offreshly
prepared trichloroethanol-chloroform (5:95)solution
and 3 drops of HFBA were added to each pH 2
fraction, and these fractions wereallowedto stand atroom temperature for 30 min. Then, 0.1 ml of
chloroformand4drops of 0.1 N HCl wereaddedto each sample, whichwas shaken and allowedtosit for 3min. Theaqueouslayerwasremoved and
dis-carded,and4dropsof 0.1NNaOHwasaddedtothe organic layer. Thiswasshaken and allowedtositfor 3min. Theorganic layerwasremovedtoaclean
12-by 75-mmtesttube andconcentratedto near
dry-ness. Next, 0.1 ml of xylene was added, and the
samplewasagain evaporatedtoneardrynessinan
80to90°Csand bath underastreamofclean dry air. A second 0.1 ml of xylene was added as the final
solvent.
Two microliters of each samplewasthen injected
intotheGLC column. The columnoventemperature
wasincreased at4°C/minfrom an initial tempera-tureof110°Ctoafinaltemperatureof245°C,where itwasheldfor30min. Under theseconditions, acids varying in length from2to20carbonatomscould be detected fromasingle derivatization procedureand chromatographic run (4). Recently, we have found
that increasing the amount of HFBA from 3 to 6 drops resultsinanincrease in theamountof deriva-tiveformed.
Amines presentinthepH10extractionwere deri-vatized as follows. To the sample remaining after
the MgSO4 drying step was added 1 drop ofa 1:3
mixture of pyridine-chloroform and 6 drops of HFBA.Thismixture wasevaporated by airtoabout
0.5 drop; the tube wasthen stopperedwith a cork and heated for4min inboilingwater.The tubewas
cooled and 0.1 ml of chloroform was added. This mixture waswashed with4drops each of0.1NHCl and0.1NNaOHasdescribedabove, except that the sample was allowedto sitin the basic wash for30
min. Thechloroform layer from the basic washwas
removedtoa cleandrytesttubeandevaporatedto
neardrynessundera streamof cleandry air, and0.1
ml of ether was added as a final solvent for GLC analysis. Two microliters of each sample was
in-jected,beginningat90°Cfor8min,and thenraised
to 225°C at 4°C/min, where the temperature was
held isothermally for 30 min. Total analysis of aminesoracids andalcohols requiresapproximately 3h.
RESULTS
The 12 samples from patients with proven
tuberculousmeningitisintheearly stagewere
remarkablysimilar in boththeamines detected
inthe HFBA derivative fromthepH10extract
and in the acids and alcohols detected in the
trichloroethanol derivative from thepH2.0
ex-tract. The samepatternwas found in CSF from
fiveclinically suspected cases. Figure 1 shows
chromatograms obtainedfrom the CSF of four
different patientswithculture-proven
tubercu-lous meningitisby usingthe pH 10 HFBA
de-rivative. Figure 2 shows a fifth patient with
tuberculous meningitis whose CSF
demon-strates the differences noted between
speci-mensobtainedduring theacutephaseof illness
(Fig. 2A) and after successful treatment (Fig.
2B). The presenceof severalcompoundsinCSF
obtained early in the course of tuberculous
meningitis contrastssharply with their virtual
absence both in successfully treated patients
(Fig. 2B) andinthe uninfected controls.
Peaks with the same numbers in Fig. 1A
through D have the sameretention times and
maybeusedtostudy similaritiesinthe
profiles
ofpatients. Peaks numbered 1 through7 were
commontoall tracings;however, peaks6and7,
which were present in small amounts in the
original chromatogram, were notvisible in the
reduced tracing (Fig. 1B) and hence are not
labeled in that tracing. The most important
peak in these tracings is labeled KHI. It has
been identified by mass spectrometry as
3-(2-ketohexyl)indoline. Data supporting this
iden-tificationwill bereported elsewhere (6a).
KHI has been found in every case of acute
tuberculous meningitis but not in the other
types ofmeningitis studied. In serial CSF
speci-J. CLIN. MICROBIOL.
on February 7, 2020 by guest
http://jcm.asm.org/
29
RETENTION TIME (MINUTES)
225°
TEMPERATURE
FIG. 1. HFBAderivativesof the pH10extractions of CSF from four patients with meningitis due to
Mycobacterium tuberculosis. Thepeaklabeled KHI has been identified by mass spectrometry as 3-2-ketohexyl)indoline and is characteristic of tubercu-lous meningitis.
mens of fivepatients, KHI disappeared slowly over the first 2 months oftherapy; however,
when steroid therapy was used, it tended to
disappear more rapidly. Fig. 1D represents a
partially treatedcase,and the reducedamount
ofKHI present isevident. Figure 1C was
ob-tained froma1.5-mlsample ofCSF.Theeffect of reduced samplesize onthe profileingeneral,
as well as onKHI, maybe seen. The value of
this compound in distinguishing tuberculous
from cryptococcal and viral infections maybe
seenby comparing Fig. 3A tothe other tracings
inthefigure. BynotingthepresenceofKHI as partof the
typical
patternshownin Fig. 1,wehave been abletoidentify correctlytwo casesof tuberculous meningitis before the culture
re-sults were available from NAMRU-3.
Two patterns ofcryptococcal meningitis are
encountered in the pH 10 extraction (Fig. 3B
and C). The occurrence of the B and I or J
peaks, however, distinguished this disorder
from viralmeningitisinthe15samples studied.
The type IIpattern (Fig. 3B) is the same as that
previously found by Schlossberg et al.
(25)
in thislaboratory and was present in 7 of the 15specimens studied. ThetypeIpattern contains twodifferent compounds, labeledA and I. We
suspectthat the occurrence ofthe type II
pat-tern maybeduetolesserseverity ofdiseaseor
to the specimen being obtained early in the
treatmentcourse. However, inspecimensfrom
two acute culture-positive untreated cases, a
typeII pattern wasobtained. Figure 2C andD
show the effects oftreatment with
amphoteri-cinB onthe CSF ofapatient withcryptococcal
meningitis. Figure2Cwasfrom aCSFobtained
earlyinthe treatment course,
and
it is atypeIIpattern. Figure 2Dshows anormalpattern in
thispatientafter6weeks of therapy.
Afurtherpossible cause for the two patterns
may be real metabolic differences among the
three serogroups of Cryptococcus neoformans.
To study this, we inoculated serogroups A, B,
and C intoneisseriadefined medium and
ana-lyzed the spent culture medium for metabolic products, using the procedures described
ear-lier(19). Serogroup Adidnotproduceanamine
thatwasproduced byBand C. Serotype C did
not produce five acids that were produced by both A and B. Thus,
metabolic
differences do existbetween serogroups.Figure 3DandE demonstrate the major
pat-Patient #2497
Acute tuberculous
meningitis
Patient #2497
w \ After 6months of therapy
cn \fortuberculosis meningitis
w JG-H
w \ Cryptococcalmeningitis
earlytreatment phase
90°C 225°C
FIG. 2. Effect oftreatment on acute tuberculous
and cryptococcal meningitis. HFBA derivatives of
amines inCSFofapatient withacute(A) and treated (B) tuberculous meningitis and ofa patient with
acute(C) and treated(D)cryptocococcal meningitis.
BandD arelike normal CSF. VOL. 6, 1977
on February 7, 2020 by guest
http://jcm.asm.org/
Thispatternrecurred with the exacerbationsof
KHI thispatient's illness, which hasbeen described
Acutetuberculous in detail elsewhere (14). The MNO
complex
ofmeningitis peaks distinguishes this type of meningitis
A from the othertypes studied.
A further demonstration of differences in
l1J viral cases may be seen in Fig. 4, which
com-DS-14 pares the pH 2 derivatized extract ofsamples
N
AD
\ Cryptococcal meningitis obtained from patients in two separateclus-K ~~~~~TypeIIPattern
B tered outbreaks of clinically diagnosed aseptic
meningitis, one patient with biopsy-proven
herpes simplex encephalitis, and two patients
Xd)
lXIJG-H
with herpes zoster-associated encephalitis. Thez rAIH lj t PCryptococcolmeningitis patterns are easily
distinguishable
by visualR~~ ~ ~ ~~~Tp atrnarditnusbl
inspection
ofthechromatograms.
Qu I K | Herpessimplex
DISCUSSION
l,,encephalitis Thetheoretical and
practical
considerationsD involved in applying GLC to the analysis of
infected body fluids were discussed by Cherry
and Moss in 1969 (13).
Recently,
Brooks hasEcho 4meningitis reviewed advances in methodology and
equip-E_
Jt ment which have established the feasibility of_
E this
approach
todiagnosis
(J.B. Brooks,Micro-JG-B
biology-1975,
p.45-54,
AmericanSociety
forAcute
Toxoplosmcgondii
Microbiology, Washington, D.C., 1975). Previ-meningitisously,
Mitruka etal.suggested
thattheinter-J No action of the host and infecting agent could
F produce compounds whose detection by GLC
5 10 15 20 25 30 35 40 45 5'5 60 65 70 75 o085 mightleadto arapid
diagnostic
technique
(17).___-TIME---
TIME The implications and desirability of thisap-900C 225'C proachhavebeendiscussedrecently by
Schloss-FIG. 3. Comparison ofamine patterns associated
with tuberculous, cryptococcal, viral, and toxo- AsepticMeningitis
plasma meningitis. The distinctive compound
associ-ated with tuberculous meningitis,
3-(2'-ketohexyl)-indoline, may be seen in tracing A (peak labeled
KHIL.A
ternsassociated with viral central nervoussys- AsepticMeningitis
tem (CNS) infections.
Chromatographic
peaksa-ofimportance for distinguishing viral from C. rB
neoformans infection are under brackets in _
Fig. 3B through E. Further, the viral patterns
,l
HerpesiSimple
(Fig. 3D and E) do nothave peaks B, I, orJ, Encephalitis
which were present in cryptococcal meningitis,
(lcoses)
but
they
do have peaks 1 or 1and 2 plus the CFGH complex.
Although the distinctive FGH complex is Herpes Zoster
consistent in the 14 viral specimens studied to Encephlitis
date, different patterns do seem to be associated
with different viruses. This may be seen in D
5 1051~2025303'54'0 5 50~560656 70i58084590
Figure 3D, obtained from apatient with herpes T
simplex encephalitis.
Peak Landthe unlabeled 145;dC --245°Cpeak precedingKare notpresent in the sample
FIG.
4. GLCprofiles ofvarious viral CNSinfec-from an ECHO-4 meningitis patient (Fig. 3E).
tions (pH
2extraction).
TrichloroethanolderivativesFigure 3F shows the amine pattern associated of acids and alcohols detected in viral meningitis
with a case ofToxoplasmagondii meningitis. andencephalitis.
30 CRAVEN ET AL. J. CLIN. MICROBIOL.
on February 7, 2020 by guest
http://jcm.asm.org/
RAPID DIAGNOSIS OF MENINGITIS BY EC GLC
bergetal. (25).
That distinctive compounds are present in
the course of infection and not in the same
patient after treatment or in normal controls
hasbeendemonstratedin thisstudy, as well as
in studies of cryptococcal meningitis (25),
tu-berculousmeningitis in primates (J. B. Brooks,
L.
Thacker,
R.Broderson,
and E. R. Beam,unpublished data), andseptic arthritis (7).
Us-ing adifferent GLC technique,Amundsonetal.
havealsoshownchanges occurringin response
tocryptococcal and other meningitidies (2). The
presence ofalarge numberofcompounds
dur-inginfection andtheabilityto detect them by ultrasensitive GLC techniques offer
possibili-ties for future investigations.
The origin of these compounds detected by
GLC, whether from infected hostcells,
inflam-matory response, or metabolic products of the
organismitself, is unknown.
Schlossberg
etal.showed that C. neoformans grown in vitro in
normal human CSF produced a chromato-graphic pattern similartothatdetectedin
nat-urally infected CSF (25). In the case of viral
infection, however, it isreasonable to assume
that thecompoundsarefromtheinfectedtarget
tissue or associated
inflammatory
cells.What-everthe origin of these compounds, the possi-bility of theirbeing involvedinthe pathophysi-ologyofmeningitisis animportantquestion for further study. If
they
are shownto beimpor-tant inthe diseaseprocess, then anew
neuro-pharmacological approachto therapy
might
bepossible.
The compound KHI found in tuberculous
meningitis is of interest because ofits
struc-tural similaritiesto
indolic-type compounds
of neurochemical importance, suchasmelatonin.The amine derivatization procedure described above does not derivatize
hydroxy-substituted
indolic compounds, such as serotonin and
5-hydroxyindoleaceticacid. Thismaybearesult
ofdegradation of these
compounds
atthehigh
pH used during extraction (pH 10).
Thus,
wemay assume that amines of this type are not
producing the peaks noted in the
chromato-gramsofFig. 3. Ultimate determination of the
structures of these
compounds
by
massspec-trometry willrequire
obtaining
themingreaterconcentration, since the EC detector is much
more sensitive than the massspectrometer for
these types ofderivatives. This
difficulty
maybe overcomeby trapping the
compounds
asthey
pass
throughthe EC detectororby extracting
much larger samples for CSF for
subsequent
analysis bymass spectrometry.
In agreement with the
findings
ofSchloss-berg et al. (25), our data show that different
viruses have different
chromatographic
pat-terns. However, these findings must still be
interpreted with care, since we have not col-lectedalarge enough series of samples of each virus to be assured of patternreproducibility. Further, we need to study specimens from
pa-tients with CNS neoplasia and demyelinating
disorders. The patterns associated with the clustered aseptic meningitis and the herpes zos-ter-related encephalitis, however, suggest that these patterns may indeed be specific for
cer-tain viruses. Iffurther analyses of
well-docu-mentedspecimens continue to differentiate
sys-tematically between CNS infections produced by different viruses, then GLC will be a very
useful clinical and epidemiological tool,
espe-ciallywhencontrastedwiththe poor yield from culture attempts and the time and effort re-quired to obtainseroconversiondata.
The problems of conventional diagnostic
techniques,combined withgeographically
scat-teredincidenceof viral CNSinfectionsandthe
inadequacy of sample size for analysis, have
been the majorfactors preventing conclusions
onthevalidityofthe GLCtechniquefor differ-entiatingbetweenviraletiologiesofCNS infec-tions. Wehope the data presented will
encour-age other investigators to providedocumented
2-ml specimens for further study of this
tech-nique.
Aside from the importance of adequate
sam-ple size, otherequipment, reagent, and
meth-odological details associated with this study
should benoted.Theextraction and
derivatiza-tion procedures are not complex, but they do
requirepracticetoachieve reproducibility. The
quality of reagentsused inthe analytical
proce-dureiscritical because of the extreme
sensitiv-ityof theECdetector,andsubstitutionsarenot
recommended. A temperature-programmable
gas chromatograph equipped with 24-foot (ca.
7.32-m) columns must be used to obtain the
necessary resolution ofthesecomplexmixtures.
Finally, inourexperience,neither the thermal
conductivitynorthe flameionizationdetectoris
selectiveor sensitiveenough to use inthis
ap-plication.
The datapresentedsuggestthat EC GLCcan be used to differentiate between tuberculous, cryptococcal,
viral,
and parasitic infections of the CNS. These differences are a result of thepresence ofcompounds that disappear as
pa-tients recover and are not present in normal
CSF. BycombiningGLC withmass
spectrome-try, it may bepossibleto
identify
someof thesecompoundsandthusgainfurther
insights
intothepathophysiology of CNS infections. If these compounds are toxic, new
therapeutic
ap-proaches to treating patients with meningitis
may also bepossible.
6, 1977 31
on February 7, 2020 by guest
http://jcm.asm.org/
32 CRAVEN ET AL.
ACKNOWLEDGMENTS
We thank John Bennett of the National Institutes of Health forthe assistance of the University Collaborative Study ofCryptococcal Meningitis in securing specimens and Amy Stineand Leo Kaufman of the CDC forverifyingthese specimens. We also thank Sharon Blumer of CDC for pro-viding the serogrouped specimens of C. neoformans and Michael Hattwick and colleagues for securing a wide vari-ety ofwell-documented viral specimens.
Thisresearch was supported by Naval Medical Research and Development Work UnitMR000.01.01.3121.
LITERATURE CITED
1. Alley, C. C., J. B. Brooks, and G. Choudhary. 1976. Electron capturegas-liquid chromatography of short chainacids as their2,2,2-trichloroethyl esters. Anal. Chem.48:387-390.
2. Amundson, S., A. I. Braude, andC. E. Davis. 1974. Rapid diagnosis of infection bygas-liquid chromatog-raphy: analysis of sugarsinnormaland infected cere-brospinalfluid. Appl. Microbiol. 28:298-302. 3. Brooks, J. B., C. C.Alley, and R. Jones. 1972. Reaction
ofnitrosamines withfluorinatedanhydrides and pyr-idine to form electron capturing derivatives. Anal. Chem. 44:1881-1884.
4. Brooks, J. B., C. C. Alley, and J. A. Liddle. 1974. Simultaneous esterification ofcarboxylandhydroxyl groups with alcohols andheptafluorobutyric anhy-dride for analysis by gas chromatography. Anal. Chem. 46:1930-1934.
5. Brooks, J. B.,C. C. Alley, J. W. Weaver, V. E. Green, and A. M. Harkness.1973.Practical methods for deri-vatizingand analysing bacterial metabolites with a modified automatic injector and gas chromatograph. Anal. Chem.45:2083-2087.
6. Brooks, J. B., W. B.Cherry, L. Thacker, and C. C. Alley. 1972. Analysis by gas chromatography of amines and nitrosamines produced in vivo and in vitrobyProteus mirabilis. J. Infect. Dis. 126:143-153. 6a.Brooks, J. B., G. Choudhary, R. B. Craven, D. Edman, C. C. Alley, and J. A. Liddle. 1977. Electron capture gas chromatography detection and mass spectrum identification of 3-(2'-ketohexyl)indoline in spinal fluids of patients with tuberculous meningitis. J. Clin.Microbiol. 5:625-628.
7. Brooks, J. B., D. S.Kellogg, C. C. Alley, H. B. Short, H. H.Handsfield, and B. Huff. 1974. Gas chromatog-raphy as a potential meansofdiagnosing arthritis.I. Differentiation between staphylococcal, streptococ-cal, gonococstreptococ-cal, and traumatic arthritis. J. Infect. Dis.129:660-668.
8. Brooks, J. B., D. S. Kellogg, L. Thacker, and E. M. Turner. 1971. Analysis by gas chromatography of fattyacids foundinwhole cultural extracts of Neis-seriaspecies.Can. J. Microbiol. 17:531-543. 9. Brooks, J. B., D. S. Kellogg, L. Thacker, and E. M.
Turner. 1972. Analysis by gas chromatography of hydroxy acids produced by several species of
Neis-seria. Can. J. Microbiol. 18:157-168.
10. Brooks, J. B., and W. E. C. Moore. 1969.Gas chromato-graphic analysis of aminesand othercompounds pro-duced by several species of Clostridium. Can.J. Mi-crobiol. 15:1433-1447.
11. Brooks, J. B., C. W. Moss, and V. R. Dowell. 1969. Differentiations between Clostridium sordellii and Clostridium bifermentans bygaschromatography.J. Bacteriol. 100:528-530.
12. Brooks, J. B., R. E.Weaver, H. W.Tatum,and S.A. Billingsley. 1972. Differentiation between Pseudomo-nas testosteroniand P. acidovoransby gas chromatog-raphy.Can. J. Microbiol. 18:1477-1482.
13. Cherry, W.B.,and C.W.Moss. 1969.Theroleof gas chromatography intheclinicalmicrobiology labora-tory. (Editorial)J. Infect. Dis. 119:658-662. 14. Greenlee,J. E., W. D. Johnson,Jr., J. F. Campa, L. S.
Adelman, and M.A.Sande.1975.Adult toxoplasmo-sispresentingaspolymyositis and cerebellar ataxia. Ann.Intern. Med. 82:367-371.
15. Maggs, R. J., P. L. Jones, A. J. Davies, and J. E. Lovelock.1971.Theelectron capture detector-anew mode of operation. Anal. Chem. 43:1966-1971. 16. Mitruka, B. M., and M. Alexander. 1967.
Ultrasensi-tivedetection of certain microbial metabolitesbygas chromatography. Anal. Biochem. 20:548-550. 17. Mitruka, B.M., L. E.Carmichael, and M.Alexander.
1969.Gaschromatographicdetection ofanvitroand in vivoactivities of certaincanineviruses. J.Infect. Dis. 119:625-634.
18. Morse, C. D., J. B. Brooks, and D. S. Kellogg. 1976. Electron capture gas chromatographic detection of acetylmethylcarbinol produced by Neisseria gonor-rhea. J. Clin.Microbiol. 3:34-41.
19. Moss, C.W., and W.B.Cherry.1968.Characterization of the C15 branched-chainfattyacidsof Corynebacte-rium acnes by gas chromatography. J. Bacteriol. 95:241-242.
20. Moss,C. W., and C. M.Kaltenbach. 1974.Productions ofglutaricacid:auseful criterion fordifferentiating Pseudomonas diminuta from Pseudomonas vesicu-lare.Appl. Microbiol.27:437-439.
21. Moss,C. W., D. S. Kellogg, D. C. Farshy, M. A. Lam-bert, and J. D. Thayer. 1970. Cellularfattyacids of pathogenic Neisseria. J. Bacteriol. 104:63-68. 22. Moss, C. W., M.A.Lambert, and W. H. Merwin.1974.
Comparison of rapid methods for analysis of bacterial fatty acids.Appl.Microbiol. 28:80-85.
23. Moss, C. W., S. B. Samuels, J. Liddle, and R. M. McKinney. 1973. Occurrence ofbranched-chain hy-droxyfatty acidsinPseudomonasmaltophilia.J. Bac-teriol. 114:1018-1024.
24. Moss, C. W., S. B. Samuels, and R. E.Weaver. 1972. Cellularfatty acid composition of selected Pseudomo-nasspecies.Appl. Microbiol. 24:596-598.
25. Schlossberg, D., J. B. Brooks, and J. A. Schulman. 1976.Thepossibility of diagnosing meningitis by gas chromatography. I.Cryptococcal meningitis.J.Clin. Microbiol. 3:239-245.
J. CLIN. MICROBIOL.